033270.KS
Korea United Pharm Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 16,850.00
+0.54%Next report
Analyst consensus
- Next report date
- Mar 22, 2027
- EPS estimate
- —
- Revenue estimate
- KRW 76.5B
Latest reported
- Last report date
- Oct 30, 2026
- EPS actual
- KRW 2.4K
- EPS estimate
- —
- Revenue actual
- KRW 74.6B
- Revenue estimate
- KRW 74.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 30, 2026 | — | -KRW 441 | — | KRW 68.1B |
| Jul 30, 2026 | — | KRW 2.4K | — | KRW 74.6B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 22, 2027